The filing is a routine insider intent-to-sell notice for a modest number of shares. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm execution.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $425.62entry
- T+1 · 8d ago −1.73%α −4.10% · $418.25
- T+5 · 4d ago +0.96%α −1.64% · $429.69
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Elevance Health officer Lavu Ratnakar filed a Form 144 notice of intent to sell 1,300 shares of common stock, with an approximate market value of $572,000. The shares were acquired through restricted stock vesting in 2025 and 2026. The sale is small relative to the company's $89.4B market cap and the insider's likely total holdings, making it a routine diversification event.
Key Facts
- Reporting person: Ratnakar Lavu, an officer of Elevance Health
- Proposed sale: 1,300 shares of common stock
- Estimated value: $572,000
- Shares acquired via restricted stock vesting on 03/01/2025 (773 shares) and 03/01/2026 (527 shares)
- Sale intended to be executed on NYSE
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Financial Impact
Proceeds of approximately $572,000, representing less than 0.001% of the company's $89.4B market cap
Risk Factors
- The sale may not occur; Form 144 is an intent notice only
- No additional context on the insider's total holdings is provided, so the proportional significance cannot be fully assessed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010723 |
| Document: 0001950047-26-010723-index.html | 0001950047-26-010723 |
| Document: 0001950047-26-010723.txt | 0001950047-26-010723 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers